Entities/ACRO BIOMEDICAL CO., LTD.

ACRO BIOMEDICAL CO., LTD.

Company
13 indicators

Total revenue

0

Not enough historical data

Net income

42.53K

Not enough historical data

Diluted earnings per share (diluted EPS)

0

Not enough historical data

Net cash flows from operating activities

-25.38K

Not enough historical data

Operating income

-16.38K

Not enough historical data

Operating expenses (excl. COGS)

16.38K

Not enough historical data

Financial

IndicatorLatest ValueYear

Total cost of goods sold

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

02023

Research & development expense

The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.

02024

Total assets

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

14.1K2025

Total liabilities

Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.

326.95K2024

Cash and cash equivalents

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

24.36K2021

Total stockholders' equity

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

-386.96K2025

Net cash provided by financing activities

Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.

25.15K2025